
Stereotaxis STXS
$ 1.94
0.0%
Annual report 2025
added 03-12-2026
Stereotaxis Depreciation & Amortization 2011-2026 | STXS
Annual Depreciation & Amortization Stereotaxis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 626 K | 587 K | 595 K | 429 K | 106 K | 126 K | 123 K | 513 K | 554 K | 368 K | 320 K | 414 K | 919 K | 1.3 M | 1.46 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 M | 106 K | 563 K |
Quarterly Depreciation & Amortization Stereotaxis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 156 K | - | - | 140 K | - | - | 160 K | - | 298 K | 194 K | 100 K | - | 80 K | 54 K | 27 K | - | 86.5 K | 58.3 K | 30.1 K | - | 88.8 K | 56 K | 24.9 K | - | 394 K | 282 K | 140 K | - | 413 K | 277 K | 141 K | - | 277 K | 186 K | 97.4 K | - | 223 K | 134 K | 70.3 K | - | 335 K | 237 K | 137 K | - | 706 K | 495 K | 263 K | - | 990 K | 669 K | 344 K | - | 1.1 M | 731 K | 359 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 M | 24.9 K | 271 K |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.57 M | $ 10.84 | -1.35 % | $ 26.3 M | ||
|
The Cooper Companies
COO
|
377 M | $ 64.8 | 0.59 % | $ 12.9 B | ||
|
iRhythm Technologies
IRTC
|
20.7 M | $ 126.86 | 3.69 % | $ 4.06 B | ||
|
Repro Med Systems
KRMD
|
810 K | $ 4.06 | 2.48 % | $ 188 M | ||
|
Microbot Medical
MBOT
|
47 K | $ 2.17 | -1.14 % | $ 99.4 M | ||
|
Milestone Scientific
MLSS
|
78.2 K | $ 0.32 | 0.87 % | $ 26.3 M | ||
|
Haemonetics Corporation
HAE
|
116 M | $ 61.2 | 2.03 % | $ 3.08 B | ||
|
electroCore
ECOR
|
501 K | $ 6.17 | -0.08 % | $ 52.3 K | ||
|
ICU Medical
ICUI
|
201 M | $ 123.61 | -0.97 % | $ 3.05 B | ||
|
Envista Holdings Corporation
NVST
|
116 M | $ 26.77 | -0.09 % | $ 4.5 B | ||
|
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
600 M | $ 475.23 | -1.45 % | $ 170 B | ||
|
West Pharmaceutical Services
WST
|
171 M | $ 302.36 | -1.15 % | $ 21.9 B | ||
|
Glaukos Corporation
GKOS
|
33.7 M | $ 122.18 | 0.43 % | $ 5.92 B | ||
|
STERIS plc
STE
|
476 M | $ 221.81 | 0.03 % | $ 21.9 B | ||
|
Masimo Corporation
MASI
|
103 M | $ 178.63 | - | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
13.4 M | $ 10.77 | 4.16 % | $ 222 M | ||
|
Teleflex Incorporated
TFX
|
178 M | $ 136.01 | -0.4 % | $ 6.07 B | ||
|
Merit Medical Systems
MMSI
|
123 M | $ 67.5 | -1.58 % | $ 3.99 B | ||
|
Utah Medical Products
UTMD
|
826 K | $ 67.0 | -0.25 % | $ 217 M | ||
|
Pulse Biosciences
PLSE
|
406 K | $ 22.84 | -0.8 % | $ 1.54 B | ||
|
DENTSPLY SIRONA
XRAY
|
352 M | $ 11.9 | -0.08 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
7.77 M | $ 0.64 | -2.11 % | $ 19.2 M | ||
|
Pro-Dex
PDEX
|
1.24 M | $ 51.5 | -1.15 % | $ 169 M | ||
|
LeMaitre Vascular
LMAT
|
10.4 M | $ 115.56 | 1.86 % | $ 2.62 B | ||
|
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
8.32 M | $ 26.37 | 2.73 % | $ 1.31 B | ||
|
BioLife Solutions
BLFS
|
5.16 M | $ 21.55 | 0.8 % | $ 993 M | ||
|
Baxter International
BAX
|
981 M | $ 18.29 | 0.72 % | $ 9.38 B | ||
|
ResMed
RMD
|
160 M | $ 221.05 | 0.61 % | $ 32.3 B | ||
|
AtriCure
ATRC
|
12.1 M | $ 29.32 | 0.14 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
1.74 M | $ 6.69 | -2.48 % | $ 297 M | ||
|
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
25.8 M | $ 11.13 | 0.27 % | $ 455 M | ||
|
Becton, Dickinson and Company
BDX
|
2.46 B | $ 151.85 | -0.18 % | $ 43.7 B | ||
|
Nephros
NEPH
|
214 K | $ 3.01 | 4.88 % | $ 31.3 M | ||
|
OraSure Technologies
OSUR
|
10.2 M | $ 2.96 | -1.5 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
68.6 M | $ 118.28 | 0.58 % | $ 6.59 M |